Register for Impetus’ upcoming live webinar on September 14, 10-11 AM ET:

A Fireside Chat with Dr. Waqaas Al-Siddiq, Founder & CEO of Biotricity

Fireside Chat with Dr. Waqaas Al-Siddiq

About the webinar

Dr. Waqaas Al-Siddiq Founder & CEO of Biotricity, will sit down with Natalie Yeadon, Co-founder & CEO of Impetus Digital, to discuss his journey from computer engineering to healthcare, innovation in the cardiac monitoring space, the concept of Mobile Cardiac Telemetry (MCT), and more. Sign up now!

Register for this free webinar

If you can’t make the date, don’t worry – sign up anyway and we’ll send you a link to the recording after the webinar.

If you would like to pass along this invite to any of your colleagues, feel free to send them this link:

Natalie Yeadon, Co-founder & CEO, Impetus Digital

Natalie Yeadon

Co-Founder & CEO

Natalie worked in the pharmaceutical industry for over 18 years in a variety of sales, marketing, and early brand commercialization management roles both in Canada and in the US, in several different therapeutic areas. She is currently the Co-Founder and CEO of Impetus Digital where she spends her time helping life science clients collaborate and create sustained, authentic relationships with their customers, virtually.

Dr. Waqaas Al-Siddiq

Dr. Waqaas Al-Siddiq

Founder & CEO

Dr. Waqaas Al-Siddiq is the founder and CEO of Biotricity, a company building a comprehensive suite of remote cardiac monitoring products, software, and services. Most remote cardiac monitors are passive — they don’t record ECG and other cardiac data in real-time — and lack cross-compatibility with other platforms/devices. Conversely, Biotricity’s core product Bioflux is a turn-key solution offering the kind of advanced, continuous monitoring that allows cardiologists to see warning signs earlier and act proactively, and integrates seamlessly into existing systems.

About Impetus Digital

Impetus Digital is the spark behind sustained healthcare stakeholder communication, collaboration, education, and insight synthesis. Our best-in-class technology and professional services ensure that life science organizations around the world can easily and cost-effectively grow and prosper—from brand or idea discovery to development, commercialization, execution, and beyond—in collaboration with colleagues, customers, healthcare providers, payers, and patients.